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Abstract
Background: The role of Lactobacillus cell wall components in the protection against pathogen infection in the gut is still
largely unexplored. We have previously shown that L. amylovorus DSM 16698T is able to reduce the enterotoxigenic F4
+Escherichia coli (ETEC) adhesion and prevent the pathogen-induced membrane barrier disruption through the regulation
of IL-10 and IL-8 expression in intestinal cells. We have also demonstrated that L. amylovorus DSM 16698T protects host
cells through the inhibition of NF-kB signaling. In the present study, we investigated the role of L. amylovorus DSM
16698T cell wall components in the protection against F4+ETEC infection using the intestinal Caco-2 cell line.
Methods: Purified cell wall fragments (CWF) from L. amylovorus DSM 16698T were used either as such (uncoated,
U-CWF) or coated with S-layer proteins (S-CWF). Differentiated Caco-2/TC7 cells on Transwell filters were infected
with F4+ETEC, treated with S-CWF or U-CWF, co-treated with S-CWF or U-CWF and F4+ETEC for 2.5 h, or pre-treated
with S-CWF or U-CWF for 1 h before F4+ETEC addition. Tight junction (TJ) and adherens junction (AJ) proteins were
analyzed by immunofluorescence and Western blot. Membrane permeability was determined by phenol red passage.
Phosphorylated p65-NF-kB was measured by Western blot.
Results: We showed that both the pre-treatment with S-CWF and the co- treatment of S-CWF with the pathogen
protected the cells from F4+ETEC induced TJ and AJ injury, increased membrane permeability and activation of NF-kB
expression. Moreover, the U-CWF pre-treatment, but not the co-treatment with F4+ETEC, inhibited membrane damage
and prevented NF-kB activation.
Conclusions: The results indicate that the various components of L. amylovorus DSM 16698T cell wall may counteract
the damage caused by F4+ETEC through different mechanisms. S-layer proteins are essential for maintaining membrane
barrier function and for mounting an anti-inflammatory response against F4+ETEC infection. U-CWF are not able
to defend the cells when they are infected with F4+ETEC but may activate protective mechanisms before
pathogen infection.
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Background
Lactobacilli, and especially Lactobacillus strains with pro-
biotic features, are considered to confer several health ef-
fects to the host. In the gastrointestinal tract these bacteria
may inhibit pathogen adhesion, modulate immune re-
sponse and protect membrane barrier function from
injurious agents and pathogens in both humans and
animals [1–5]. It is well established that the disruption
of gut membrane integrity allows pathogen entry through a
leaky barrier and leads to the development of inflammatory
reactions and intestinal diseases [6, 7]. The barrier function
is maintained through the tight junctions (TJs), formed by a
complex of proteins such as zonula occludens (ZO)-1,
occludin and claudin, that link adjacent cells and seal the
intercellular space [8]. Adherens junctions (AJs), consisting
of the transmembrane protein E-cadherin, and intracellular
catenin, contribute to cell-cell adhesion [9] and are required
for TJ formation [10].
In pigs lactobacilli, especially L. amylovorus strains, are
common members of the gut microbiota [11]. Lactobacillus
amylovorus DSM 16698T, isolated from an unweaned pig-
let, is particularly abundant in piglets [12]. This strain has
been shown to protect intestinal cells from membrane
damage and inflammation induced by enteroxigenic Escher-
ichia coli (ETEC) carrying F4 fimbriae [3, 13, 14]. F4+E. coli
strains are major causative agents of enteric infections, diar-
rhoea and mortality in piglets [15].
The mechanisms underlying the probiotic health effects
of lactobacilli are not fully understood. Recently, efforts
have been put forward to understand the role of cell wall
components in the probiotic effects. Surface (S)-layers are
located at the outermost part of the cell wall of several
Lactobacillus strains, including L. amylovorus DSM
16698T. They are composed of numerous identical pro-
tein subunits that form a symmetric and porous layer
covering the entire bacterial surface. The S-layer pro-
tein (SLP) subunits are held together and connected to
the underlying cell wall carbohydrates by non-covalent
interactions. The subunits are poorly water-soluble and
spontaneously form a layer, or precipitate, in aqueous
solutions in vitro [16]. Some studies report that SLPs,
isolated from different Lactobacillus species, mediate
bacterial adherence or inhibit pathogen adhesion [17–20],
counteract Salmonella invasion [21], protect cytoskeleton
and membrane barrier from injury [22], and exert
immunomodulatory activity [23, 24]. However, the re-
sults are insufficient or even controversial, which is
partly due to the difficulty to obtain pure, soluble S-
layer preparations [16, 25]. Hynönen et al. [25] have been
able to prepare purified cell wall fragments (CWF) coated
with recombinant L. amylovorus SLPs that allowed the
presentation of the SLPs in a native symmetric organization
resembling that present on the intact bacterial surface. They
found that L. amylovorus SLPs only poorly adhered to
intestinal cells, despite the adhesiveness of whole bac-
terial cells.
Other components of the bacterial cell wall, such as
wall teichoic and lipoteichoic acids (WTA and LTA,
respectively), have been shown to exert either pro- or
anti-inflammatory activity. For instance, Kaji et al. [26]
demonstrated that WTA and LTA revert IL-12 produc-
tion, induced by certain Lactobacillus strains, towards
IL-10 production in macrophages. Kim et al. [27] found
that LTA from L. plantarum inhibited the pathogen-
induced increase in platelet-activating factor receptor in
human monocyte-like cells. In contrast, other authors have
shown a pro-inflammatory role of L. acidophilus LTA in ex-
perimental colitis and polyposis in mice [28, 29].
Overall, there is a need to further elucidate the functions
of Lactobacillus cell wall molecules and in particular to
understand their role in the protection against pathogen in-
fection in the gut. In our previous studies, we have shown
that L. amylovorus DSM 16698T prevented the F4+ETEC-
induced disruption of TJ and cytoskeleton proteins in intes-
tinal cells through IL-10-mediated signaling involving IL-8
down-regulation [13]. In addition, we have found that this
strain inhibited the F4+ETEC-induced pro-inflammatory
response by blocking the increase in NF-kB signaling [3]. In
the present study, we have investigated the role of particu-
lar cell wall components of L. amylovorus DSM 16698T in
the protection against F4+ETEC-induced membrane barrier
damage and inflammation. We used purified CWF as such,
i.e. uncoated (U-CWF) or coated with SLPs (S-CWF)
purified from L. amylovorus DSM 16698T, according to
previous studies [25, 30]. As intestinal cells, we used
the Caco-2 cell line, expressing several morphological
and functional characteristics of mature enterocytes,
such as a well-differentiated brush border on the apical
surface and TJs [31].
Methods
Epithelial cell culture
The human intestinal Caco-2/TC7 cell line was kindly
provided by Monique Rousset (Institute National de la
Santé et de la Recherche Médicale, INSERM, France).
These cells derive from parental Caco-2 cells at late pas-
sage, exhibit a more homogeneous expression of differenti-
ation traits, and have been reported to express higher
metabolic and transport activities than the original cell line,
more closely resembling small intestinal enterocytes [32].
The cells were routinely maintained at 37 °C in an atmos-
phere of 5 % CO2/95 % air at 90 % relative humidity. The
cells were used between passages 100 and 105 and routinely
grown on plastic tissue culture flasks (75 cm2 growth area,
Becton Dickinson, Milan, Italy) in Dulbecco’s modified
minimum essential medium (DMEM; 3.7 g/L NaHCO3,
4 mM glutamine, 10 % heat inactivated fetal calf serum,
1 % nonessential amino acids, 105 U/L penicillin and
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100 mg/L streptomycin). All cell culture reagents were
from Euroclone (Milan, Italy). For the experiments, the
cells were seeded on Transwell filters (polyethylene ter-
ephtalate filter inserts for cell culture; Becton Dickinson)
of 12 mm diameter, 0.45 μm pore size, as described
below. After confluency, cells were left for 17–21 days
to allow differentiation [31]. Medium was changed 3
times a week.
Bacterial strains and culture conditions
The F4+ETEC (O149:K88ac; kindly provided by The
Lombardy and Emilia Romagna Experimental Zootechnic
Institute, Reggio Emilia, Italy) was grown in Luria-Bertani
(LB) broth containing 1 % tryptone and 0.5 % yeast extract
(both from OXOID, Basingstoke, England), plus 1 % NaCl,
pH 7.0. After overnight incubation at 37 °C with vigorous
shaking, the bacteria were diluted 1:200 in fresh LB and
grown until mid-log phase. Bacterial cells were then har-
vested by centrifugation at 3000 × g for 10 min at 4 °C and
resuspended in antibiotic- and serum-free DMEM.
L. amylovorus strain DSM 16698T, isolated from piglet
small intestine and previously called L. sobrius, (kindly
provided by H. Smidt, University of Wageningen,
Wageningen, The Netherlands) was grown in DeMan
Rogosa Sharp (MRS) medium (DIFCO, Milan, Italy) at
37 °C under anaerobic conditions.
Bacterial concentrations were determined by densitom-
etry and confirmed by serial dilutions followed by colony
forming unit (CFU) counts of F4+ETEC on LB agar after
16 h incubation, and of L. amylovorus DSM 16698T on
MRS agar after 48 h incubation at 37 °C, under anaerobic
conditions. The viability of F4+ETEC grown on DMEM did
not differ from that of bacteria grown on LB medium, as
tested in preliminary experiments by CFU counts after agar
plating of bacterial inoculates from the two different media.
L. amylovorus DSM 16698T S-CWF and U-CWF
preparations
L. amylovorus DSM 16698T S-CWF and U-CWF were
prepared as described by Hynönen et al. [25], except that
SLPs isolated from the bacterial surface [30], rather than
recombinant SLPs, were used. Briefly, SLPs were extracted
from the bacterial surface by 5 M guanidine hydrochloride
(GHCl) and purified by size exclusion chromatography in
5 M GHCl in a Sephacryl S-200 HiPrep 16/30 column,
after which CWF, prepared as described by Avall-
Jääskeläinen et al. [33], were coated with the purified
SLPs. U-CWF were used as negative controls.
Cell treatments
Caco-2/TC7 cells, differentiated on Transwell filters of
12 mm diameter (1 × 106 cells/filter) were untreated (con-
trol, C), or apically treated with 1 mL of medium contain-
ing F4+ETEC (5 × 106 CFU/mL; E), S-CWF (amount
equivalent to 5 × 107 CFU/mL of L. amylovorus DSM
16698T) or U-CWF (amount equivalent to 5 × 107 CFU/
mL of L. amylovorus DSM 16698T), or co-treated with S-
CWF or U-CWF and F4+ETEC, for 2.5 h in a humidified
atmosphere of 5 % CO2. Other cell monolayers were pre-
treated with S-CWF or U-CWF for 1 h before F4+ETEC
infection (prS-CWF+ E or prU-CWF+ E), as described
above. We determined the pathogen concentration and
time of incubation based on preliminary experiments to
allow the triggering of the inflammation pathway without
the disruption of the cell monolayer [3]. The 1:10 ratio of
F4+ETEC to L. amylovorus DSM 16698T was that used in
our previous study [13].
Localization of TJ (ZO-1 and occludin) and AJ (E-cadherin
and β-catenin) proteins
Caco-2/TC7 cells were washed three times with cold
PBS containing Ca++ and Mg++, fixed in ice-cold methanol
for 3 min, and then incubated with rabbit polyclonal anti-
ZO-1, mouse monoclonal anti-occludin, mouse monoclo-
nal anti-β-catenin, or rabbit polyclonal anti-E-cadherin
antibodies (Zymed Laboratories), for 1 h. For secondary
detection, the cells were incubated with fluorescein iso-
thiocyanate (FITC) or tetramethylrhodamine isothio-
cyanate (TRITC) conjugated secondary antibodies (Jackson
Immunoresearch, Milan, Italy), for 1 h. Stained monolayers
were mounted on glass slides by using Prolong Gold
antifade Reagent (Molecular Probes, Invitrogen, Milan,
Italy) and analyzed using a fluorescence microscope
(Zeiss, Jena, Germany).
Immunoblot analysis of TJ and AJ proteins
Cells were washed and lysed in cold radioimmunoprotein
assay buffer (RIPA: 20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 0.1 % SDS, 1 % Na deoxycholate, 1 % Triton X-100)
containing 1 mM phenylmethylsulphonyl fluoride, Protease
Inhibitor Cocktail (Complete Mini, Roche, Milan, Italy) and
Phosphatase Inhibitor Cocktail (PhosSTOP). The cells were
centrifuged at 15,000 × g for 20 min and supernatants were
recovered. Cell lysates (50 μg total proteins) were dissolved
in sample buffer (50 mM Tris-HCl, pH 6.8, 2 % SDS, 10 %
glycerol, 100 mg/mL bromophenol blue, 10 mM β-
mercaptoethanol), heated for 5 min, fractionated by
SDS polyacrylamide gel electrophoresis and transferred
to nitrocellulose filters (Whatman Protran, PerkinElmer,
Milan, Italy). The membranes were incubated with the
following primary antibodies: mouse monoclonal anti-
occludin (Zymed Laboratories, Milan, Italy), rabbit
polyclonal anti-β-catenin, anti-phospho β-catenin, anti-E-
cadherin and anti-α-tubulin (Cell Signaling Technology,
Danvers, MA) at a concentration of 2 mg/L in 3 % BSA, for
1 h. The membranes were then incubated with horseradish
peroxidase-conjugated secondary antibodies (Cell Signaling
Technology), for 1 h. Proteins were detected using
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enhanced chemiluminescence reagent (ECL kit LiteAblot
Extend, Euroclone), followed by analysis of chemilumines-
cence with the CCD camera detection system Las4000
Image Quant (GE Health Care Europe GmbH, Milan, Italy).
Relative expression levels of occludin, β-catenin and E-
cadherin proteins were normalized to α-tubulin, whereas
the phosphorylated β-catenin was normalized to the corre-
sponding unphosphorylated form.
Cell permeability
Cell permeability was measured by phenol red passage,
according to Ferruzza et al. [34]. Briefly, following three
washes of cell monolayers with PBS containing Ca++ and
Mg++, 0.5 mL of 1 mM phenol red was added in the apical
(AP) compartment, whereas 1 mL of PBS was added in
the basolateral (BL) compartment. After 1 h of incubation
at 37 °C, 0.9 mL of BL medium was collected, treated with
0.1 mL of 0.1 N NaOH and read at 560 nm to determine
the phenol red concentration (Tecan Infinite M200 micro-
plate reader, Tecan Italia, Milan, Italy). The phenol red
passage was expressed as apparent permeability (P app),
as previously described [34]. The TJs were considered
open when the apparent permeability of phenol red was ≥
1 × 10−6 cm x s−1.
Immunoblot analysis of NF-kB activation
The cells were processed as described above for immu-
noblot analysis of TJ and AJ proteins. After separation
by SDS polyacrylamide gel electrophoresis and transfer
to nitrocellulose filters, the membranes were incubated
with rabbit polyclonal anti-p65 or anti-phospho(P)-p65
primary antibodies (Cell Signaling Technology, Danvers,
MA) and then with horseradish peroxidase-conjugated
secondary antibodies (Cell Signaling Technology). Chemi-
luminescence was analyzed as described above. The rela-
tive expression level of the phosphorylated protein was
normalized to its corresponding unphosphorylated form.
Statistical analysis
The significance of the differences was evaluated by one-
way ANOVA followed by post-hoc Tukey HSD test. The
significance was set at P values < 0.05. The symbol * was
used to indicate significant difference from the control
group, whereas the symbol # was used to indicate signifi-
cant difference from the ETEC group. All statistical ana-
lyses were performed with the software program “Statistica”
(version 5.0; StatSoftInc, Tulsa, OK).
Results
Different protection of membrane barrier integrity by L.
amylovorus DSM 16698T S-CWF and U-CWF
To verify whether L. amylovorus SLPs and/or U-CFW
were crucial for protection against the barrier damage
induced by F4+ETEC, we analyzed the major TJ and AJ
proteins, as well as membrane permeability in Caco-2/
TC7 cells pre-treated with S-CWF or U-CWF and then
infected with F4+ETEC, or co-treated with S-CWF or U-
CWF and F4+ETEC.
Localization of ZO-1, occludin, E-cadherin and β-catenin
The immunolocalization of TJ proteins is shown in Fig. 1.
The treatment of Caco-2/TC7 cells with either S-CWF or
U-CWF alone did not modify ZO-1 and occludin
localization around the cell boundaries. Infection with F4
+ETEC caused TJ disruption, as indicated by ZO-1 and
occludin delocalization from the membrane with scattered
distribution of occludin inside the cells. The pre- and co-
treatments of infected cells with S-CWF protected the cell
membrane by maintaining the correct distribution and
organization of TJ proteins. The membrane integrity was
also preserved by the pre-treatment with U-CWF before
F4+ETEC infection, however, a few cells showed occludin
delocalization . On the other hand, the co-treatment with
U-CWF was not able to counteract the membrane
damage. The localization of E-cadherin and β-catenin
(Fig. 2) was not affected by the treatment with S-CWF
and U-CWF alone. F4+ETEC induced severe architectural
disturbance of both proteins, as shown by irregular stain-
ing indicating displacement of the proteins from cell-cell
junctions. In the presence of F4+ETEC, the S-CWF treat-
ments counteracted all the alterations induced by this
pathogen preserving the correct distribution and
organization of the AJ proteins. On the contrary, the co-
treatment with U-CWF and F4+ETEC did not preserve
the AJ structure. However, when U-CWF were given to
the cells before F4+ETEC infection, a correct AJ protein
localization was found with the exception of few cells
showing some delocalization of these proteins.
Immunoblot of occludin, β-catenin, P-β-catenin and E-cadherin
To confirm the ETEC-induced alterations in TJ and AJ
protein localization and the protection by L. amylovorus,
we have analyzed the abundance of these proteins
(Fig. 3). Panel A shows a representative Western blot of
each protein. A strong decrease in the amount of occlu-
din (panel B), β-catenin (panel D) and E-cadherin (panel
C) was observed in the cells infected with ETEC com-
pared with the control group. Both the pre- and co-
treatments with S-CWF inhibited these alterations, since
the amounts of occludin, β-catenin and E-cadherin of S-
CWF-treated cells were significantly higher than those
of ETEC-treated cells and did not differ from those of
control cells (panels B-D). Protection was induced by U-
CWF only when added before F4+ETEC infection but
not when co-treated with F4+ETEC. In fact, a decrease
in all the TJ and AJ proteins similar to that induced by
ETEC was observed in the cells co-treated with U-CWF
and ETEC, while the amounts of occludin, β-catenin and
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Fig. 1 S-layer protein-coated or uncoated cell wall fragments differently protect tight junctions (TJs) in F4+ETEC infection. Caco-2/TC7 cells were: untreated
(control, C), infected with ETEC (E), treated with S-layer protein-coated cell wall fragments (S-CWF) or uncoated cell wall fragments (U-CWF), co-treated with
S-CWF or U-CWF and E (S-CWF + E or U-CWF + E, respectively), pre-treated with S-CWF or U-CWF before F4+ETEC infection (prS-CWF + E or prU-CWF + E,
respectively). Cells were labelled with specific primary antibodies for ZO-1 and occludin, followed by FITC- and TRITC- conjugated secondary antibodies for
ZO-1 and occludin, respectively. The figure shows the interruption of continuous staining of ZO-1 and occludin, resulting in dissociation of the proteins
from membranes in F4+ETEC infected and U-CWF + F4+ETEC treated cells (arrows). Regular localization of TJ proteins is visible in cells pre-treated with
S-CWF or co-incubated with S-CWF and F4+ETEC. A delocalization of occludin is present only in few cells pre-treated with U-CWF (arrow). Each figure is
representative of three independent immunofluorescence assays (63 × magnification). Bars represent 10 μm
Fig. 2 S-layer protein-coated or uncoated cell wall fragments differently protect adherens junctions from F4+ETEC-induced injury. Caco-2/TC7 cells
were: untreated (control, C), infected with F4+ETEC (E), treated with S-layer protein-coated cell wall fragments (S-CWF) or uncoated cell wall fragments
(U-CWF), co-treated with S-CWF or U-CWF and E (S-CWF + E or U-CWF + E, respectively), pre-treated with S-CWF or U-CWF before F4+ETEC infection
(prS-CWF + E or prU-CWF + E, respectively). Cells were labelled with specific primary antibodies for E-cadherin and β-catenin, followed by FITC- and
TRITC-conjugated secondary antibodies for E-cadherin and β-catenin, respectively. The figure shows the displacement of the proteins from cell-cell
junctions in F4+ETEC infected and U-CWF + F4+ETEC treated cells (arrows). The regular cell-cell interactions is preserved in cells pre-treated with S-CWF
or co-incubated with S-CWF and ETEC. An irregular staining of the proteins is present only in few cells pre-treated with U-CWF (arrows). Each figure is
representative of three independent immunofluorescence assays (63 × magnification). Bars represent 10 μm
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E-cadherin in the cells pretreated with U-CWF did not
differ from those of control cells (panels B-D). We have
also analyzed the phosphorylation of β-catenin (panel E),
which in this form is known to dissociate from cell-cell
contacts and accumulate in the cytoplasm [35]. F4+ETEC
significantly increased the level of β-catenin phosphoryl-
ation compared with control cells. When the cells were
pre-treated with S-CWF or U-CWF and co-treated with
S-CWF and F4+ETEC the value of β-catenin phosphoryl-
ation did not differ from that of control cells. However,
also in this case, U-CWF when co-treated with F4
+ETEC was not able to inhibit the increase in β-catenin
phosphorylation. The treatment of the cells with S-
CWF or U-CWF alone did not induce any change in
these proteins, as compared with control cells.
TJ permeability
Membrane barrier permeability was determined in
Caco-2/TC7 cells by the paracellular flux of the phe-
nol red marker (Fig. 4). The results were consistent
with those of Western blot and immunofluorescence
localization. In fact, F4+ETEC induced a significant in-
crease in phenol red passage that was not observed
after the pre- and co-treatments of infected cells with
S-CWF. The pre-treatment, but not co-treatment with
U-CWF, completely prevented the ETEC-induced phenol
red passage increase. The treatment of the cells with S-
CWF alone did not affect membrane permeability. In U-
CWF treated cells, the phenol red passage was higher than
that of control cells, but much lower than the reference
value indicating an opening of TJ (1 × 10−6 cm x s−1).
Fig. 3 S-layer protein-coated or uncoated cell wall fragments dissimilarly counteract F4+ETEC-induced injury of membrane barrier. Caco-2/TC7
cells were untreated (control, C), infected with F4+ETEC (E), treated with S-layer protein-coated (S-CWF) or uncoated cell wall fragments (U-CWF),
co-treated with S-CWF or U-CWF and E (S-CWF + E or U-CWF + E, respectively), pre-treated with S-CWF or U-CWF before F4+ETEC infection (prS-CWF + E
or prU-CWF + E, respectively). Cell lysates were fractionated by SDS-PAGE and transferred to nitrocellulose filters. The membranes were incubated with
mouse monoclonal anti-occludin and rabbit polyclonal anti-β-catenin, anti-phospho (P)-β-catenin, anti-E-cadherin, anti-α-tubulin primary antibodies, and
then with horseradish peroxidase-conjugated secondary antibodies. The figure shows a representative Western blot of each protein (panel a) and the
densitometric values of the immunoreactive protein bands (panels b–e). The relative expression levels of occludin, β-catenin and E-cadherin
were normalized to α-tubulin, whereas the phosphorylated β-catenin was normalized to the corresponding unphosphorylated form. Values
represent means ± SD of at least three independent experiments, carried out in triplicate. Statistically significant differences are shown and *
indicates P < 0.01 from the control group, # indicates P < 0.05 from the ETEC group
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Inhibition of F4+ETEC-induced NF-kB activation by L.
amylovorus DSM 16698T S-CWF and U-CWF
We further investigated whether the protection by L.
amylovorus DSM 16698T S-CWF and U-CWF was elic-
ited through the inhibition of NF-kB signaling (Fig. 5).
The infection of Caco-2/TC7 cells with F4+ETEC re-
sulted in NF-kB activation, as shown by a significant in-
crease in the level of the phosphorylated form of NF-kB
subunit p65. This inflammatory response towards F4+ETEC
was inhibited by S-CWF added either before (pre-treat-
ment) or simultaneously (co-treatment) with the pathogen,
as well as by the pre-treatment with U-CWF.
Discussion
The disruption of intestinal barrier function may favor
an indiscriminate passage of pathogens leading to an im-
pairment of the mucosal immune system and the devel-
opment of intestinal inflammatory diseases [6, 7]. In our
previous study, we have shown that L. amylovorus DSM
16698T reduces the adhesion of F4+ETEC and prevents
the pathogen-induced disruption of TJ and cytoskeleton
proteins through IL-10-mediated signaling involving down-
regulation of IL-8 [13]. We have recently also demonstrated
that the same L. amylovorus DSM 16698T strain inhibits
the F4+ETEC-induced increase in NF-kB signaling [3]. In
the present study, we show that SLPs isolated from L.
amylovorus DSM 16698T, either in the pre-treatment
before F4+ETEC infection or co-treatment with the
pathogen, protected Caco-2/TC7 cells from the pathogen-
induced TJ and AJ injury, increase in membrane permeabil-
ity, and NF-kB activation. In other reports, a pre-treatment
of T84 cells with SLP extracts from L. helveticus, before E.
coli O157:H7 infection, was able to preserve membrane
barrier function, while a co-treatment did not protect [18].
Interestingly, we also found that U-CWF were able to in-
hibit the membrane injury and NF-kB activation, but only
if added to the cells before F4+ETEC infection. To our
knowledge, this is the first report showing protection of in-
testinal cells from pathogen-induced injury by U-CWF.
These results suggest that different components of L. amy-
lovorus DSM 16698T cell wall may counteract the damage
caused by F4+ETEC and that different mechanisms are in-
volved in the protection exerted by SLPs and U-CWF.
The functions of SLPs are still largely unknown. A
possible mechanism explaining the protection against
pathogens by SLPs is the competition for binding sites
on intestinal cells, based on the ability of such proteins
to mediate cell adhesion. For instance, the SLPs of L.
crispatus inhibited adhesion of three different diarrhoea-
genic E. coli strains (ETEC ATCC31705, enteroinvasive
E. coli IID955 and enteropathogenic E. coli IID956) to
Fig. 4 S-layer protein-coated- or uncoated-cell wall fragments
protect against F4+ETEC-induced increase in membrane permeability
differently. Caco-2/TC7 cells were untreated (control, C), infected
with F4+ETEC (E), treated with S-layer protein-coated (S-CWF) or
uncoated-cell wall fragments (U-CWF), co-treated with S-CWF or
U-CWF and E (S-CWF + E or U-CWF + E, respectively), pre-treated
with S-CWF or U-CWF before F4+ETEC infection (prS-CWF + E or
prU-CWF + E, respectively). Phenol red was added in the apical
(AP) compartment, for 1 h, and then determined spectrophotometrically
in the basolateral (BL) compartment. The results are expressed as
apparent permeability (P app). Values represent means ± SD of at
least three independent experiments, carried out in triplicate. Statistically
significant differences are shown and * indicates P < 0.001 from
the control group, # indicates P < 0.001 from the ETEC group
Fig. 5 Inhibition of F4+ETEC-induced NF-kB activation by S-layer
protein–coated or uncoated -cell wall fragments. Caco-2/TC7 cells
were untreated (control, C), infected with ETEC (E), treated with
S-CWF or U-CWF, co-treated with S-CWF or U-CWF and E (S-CWF +
E or U-CWF + E, respectively), pre-treated with S-CWF or U-CWF
before F4+ETEC infection (prS-CWF + E or prU-CWF + E, respectively).
Cell lysates were fractionated by SDS-PAGE and transferred to
nitrocellulose filters. Membranes were incubated with rabbit
polyclonal anti-p65 or anti-phospho (P)-p65 primary antibodies
and then with horseradish peroxidase-conjugated secondary anti-
bodies. The figure shows the densitometric values of phospho (P)-p65
protein, normalized to its corresponding unphosphorylated form. Values
represent means ± SD of three independent experiments, carried out in
triplicate. Statistically significant differences are shown and * indicates
P < 0.001 from the control group, # indicates P < 0.05 from the
ETEC group
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the basement membrane through competition for bind-
ing sites with laminin molecules [19]. The pre-treatment
of epithelial cells with SLPs from L. helveticus decreased
enterohaemorrhagic E. coli adherence, attaching-effacing
lesions and membrane barrier damage [18]. A reduced
infection of S. typhimurium was associated with com-
petitive exclusion in the gut and an enhanced immune
protection conferred by the SLPs of L. helveticus in mice
[20]. The ability of the SLPs from kefir-isolated L. kefir
strains to co-aggregate with yeast Saccharomyces lipoly-
tica, present in kefir grains [36], was associated with the
inhibition of Salmonella invasion in intestinal cells [21].
However, the results of these studies are not fully con-
clusive, since SLPs in these preparations have not been
purified and in soluble form [16]. Hynönen et al. [25]
overcame this problem by a method based on the self-
assembly of recombinant L. amylovorus DSM 16698T
SLPs on purified cell wall fragments to minimize SLP’s
auto-precipitation and to allow the presentation of the
proteins in the native organization, similar to that seen
on the bacterial surface. These authors further studied
the adhesive capacity of SLPs to porcine intestinal IPEC-
1 cells by using SLP-CWF preparations with different
SLPs isolated from several L. amylovorus strains. Sur-
prisingly, they found a very low level of adhesion to in-
testinal cells by the SLPs of L. amylovorus DSM 16698T.
This fact suggests that the protection elicited by S-CWF
against F4+ETEC infection was not achieved through
competition with the pathogen for binding sites. Al-
though here Caco-2 instead of IPEC-1 cells were used, it
is unlikely that S-CWF were able to induce a remarkable
inhibition of F4+ETEC adhesion to Caco-2 cells. In fact,
IPEC-1 and Caco-2 cells perform similarly in adhesion
inhibition assays with intact L. amylovorus DSM 16698T
cells and F4+ETEC (data not shown). Moreover, even if a
limited reduction of F4+ETEC attachment to Caco-2
cells had been induced by S-CWF, a sufficient number
of pathogens would have adhered releasing toxins and
causing membrane damage and inflammatory responses.
Thus, beyond inhibition of adhesion, other mechanisms
were involved in the protection elicited by S-CWF
against F4+ETEC infection. This is in agreement with
previous findings showing that an efficient inhibition of
pathogen adhesion by different Lactobacillus strains is
not necessary for the protection against pathogen-induced
injury and that multiple mechanisms are responsible for
the protective activities [3, 37–39].
In our previous studies, we have shown that L. amylo-
vorus DSM 16698T suppresses the activation of the dif-
ferent steps of TLR4 signaling in intestinal cells by
inhibiting the F4+ETEC-induced increase of TLR4 and
MyD88 levels, as well as the phosphorylation of the
IKK-α, IKK-β, IkB-α and NF-kB subunit p65 [3]. These
changes were associated with a decrease of inflammatory
cytokines, including IL-8 that was involved in F4+ETEC-
induced TJ injury [13]. In the present study, we found
that L. amylovorus DSM 16698T SLPs are essential to ac-
tivate protective immune regulation in response to F4
+ETEC infection, since the co-treatment of S-CWF with
the pathogen inhibited NF-kB activation, while the co-
treatment of U-CWF with F4+ETEC was ineffective. On
the basis of previous and present results, we can suggest
that the ability of isolated L. amylovorus DSM 16698T
SLPs to maintain membrane barrier structure and func-
tion is achieved through regulation of NF-kB mediated
cytokine secretion.
The immunomodulatory importance of SLPs from dif-
ferent Lactobacillus species has also been demonstrated
by previous studies. Konstantinov et al. [23] identified
the SLPs of L. acidophilus NCFM as the binding ligand
for dendritic cell-specific ICAM-3-grabbing non integrin
(SIGN3), involved in the modulation of dendritic and T
cells functions. Other authors have shown that the SLP
purified from L. acidophilus NCK2187 binds to C-type
lectin SIGNR3, which leads to a reduction of pro-
inflammatory signals, mitigation of colitis and protection
of gut barrier function in pathogenic T-cell-induced col-
itis in mice [40]. A modulation of innate immunity with
inhibition of NF-kB activation was induced by the SLPs
of L. helveticus MIMLh5 in Caco-2 cells, but not in hu-
man macrophages, where on the contrary, an increase of
pro-inflammatory factors was found [24]. Johnson et al.
[41] found reduced TNF-α production by dendritic cells
when co-incubating them with a L. acidophilus NCFM
LBA1029 deletion mutant lacking the Lba-1029 gene
that encodes a putative S-layer associated protein, thus
indicating that this SLP-associated protein is involved in
the pro-inflammatory TNF-α response. Notably, in none
of these studies a pathogen challenge was included.
However, a recent study found an ability of the SLPs iso-
lated from L. acidophilus to inhibit Salmonella-induced
activation of MAPK signaling [22]. Consistent with this
finding, our study highlights the role of SLPs in the gut
protection against pathogen infection through the stimu-
lation of innate immunity.
In our previous study, we have shown that TLR2
was required for the suppression of F4+ETEC induced
TLR4 signaling activation by L. amylovorus DSM
16698T [3]. Here, the fact that already a pre-treatment
with U-CWF, prior to F4+ETEC infection, was able to
block NF-kB activation, suggests that components of
CWF may trigger protective mechanisms, including
TLR2 activation, before F4+ETEC infection, which
leads to NF-kB inhibition. LTA is a well-known and
potent ligand of TLR2 [42]. As LTA was not present in
the U-CWF preparation, we can speculate that WTA,
similar in extracellular structure to LTA, had a role in
TLR2 activation.
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Previous studies have shown a pro-inflammatory role
of LTA in intestinal inflammation. Mohamadzadeh et al.
[28] found a down-regulation of IL-12 and TNF-α and
amelioration of dextran sulphate-induced colitis in mice
treated with L. acidophilus NCFM deficient in LTA.
Other authors have found that oral treatment of mice
with LTA-deficient L. acidophilus NCK2025 resulted in
a reduction in inflammation and protection against co-
lonic polyposis [29]. However, our results are in agree-
ment with previous studies conducted in the presence of a
pathogen, showing that LTA from L. plantarum exerted
anti-inflammatory effects by inhibiting the NF-kB medi-
ated increase in platelet-activating factor receptor induced
by Staphylococcus aureus [27]. Moreover, WTA and LTA
were identified as key factors for triggering the induction
of IL-10 production mediated by TLR2-dependent ERK
activation in macrophages [26].
Conclusions
Our results indicate that the S-layer proteins from L.
amylovorus DSM 16698T are essential for maintaining
membrane barrier function and mounting an anti-
inflammatory response to F4+ETEC infection. Con-
versely, U-CWF are able to protect the cells through
mechanisms exerted before pathogen infection.
In addition, this study supports the notion that not only
viable probiotics induce health effects, but also their cell
wall components or dead/inactivated bacteria induce
beneficial immune and other biological responses, as re-
cently reviewed [43–45]. Thus, our results suggest that
the supplementation of Lactobacillus cell wall compo-
nents may represent a therapeutic strategy to prevent or
ameliorate infectious diseases in the gastrointestinal tract.
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